Doxycycline alters metabolism and proliferation of human cell lines

Ethan Ahler1, William J Sullivan, Ashley Cass

  • 1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.

Plos One
|June 7, 2013
PubMed

Insights

Doxycycline, used in gene expression systems, alters human cell metabolism towards glycolysis and slows proliferation. Researchers should implement controls for these off-target effects in experiments.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Tetracycline antibiotics, including doxycycline, are crucial for inducible gene expression in research.
  • Known effects include mitochondrial ribosome inhibition, but off-target impacts at common experimental concentrations are less understood.

Purpose of the Study:

  • To investigate the off-target effects of doxycycline on human cell lines at concentrations typical for inducible gene expression systems.
  • To assess the impact on gene expression, cellular metabolism, and proliferation.

Main Methods:

  • Exposure of human cell lines to commonly used doxycycline concentrations.
  • Analysis of gene expression patterns.
  • Measurement of metabolic parameters (lactate secretion, oxygen consumption).
  • Assessment of cell proliferation rates.

Main Results:

  • Doxycycline treatment altered gene expression profiles in human cells.
  • A metabolic shift towards glycolysis was observed, indicated by increased lactate production and decreased oxygen consumption.
  • Cell proliferation was significantly reduced at the tested doxycycline concentrations.

Conclusions:

  • Commonly used doxycycline concentrations can induce significant off-target effects on cellular metabolism and proliferation.
  • These metabolic and proliferative changes may confound results from inducible gene expression studies.
  • Researchers must incorporate appropriate controls to mitigate potential confounding effects of doxycycline in their experimental designs.

Related Concept Videos

Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs01:21

Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in determining the metabolic...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...